Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Cell Count × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Recurrence 1 Peritoneal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Immunologic Deficiency Syndromes 1 Glioblastoma 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Adenoviridae Infections 1 Abdominal Neoplasms 1

Interventions

pembrolizumab 69 Cyclophosphamide 32 Nivolumab 31 Blood Specimen Collection 31 Standard of Care 30 Bevacizumab 29 Carboplatin 28 Surveys and Questionnaires 24 Paclitaxel 24 atezolizumab 21 Dexamethasone 20 Radiotherapy 19 Pemetrexed 19 Fluorouracil 19 Docetaxel 19 Leucovorin 18 Oxaliplatin 17 Cisplatin 17 Gemcitabine 16 Exercise 16 Irinotecan 15 fludarabine 14 Interviews as Topic 14 Capecitabine 13 dostarlimab 12 Rituximab 12 Drug Therapy 12 Cetuximab 12 Prednisone 11 130-nm albumin-bound paclitaxel 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05887882 2026-03-16

PNOC028

University of California, San Francisco

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡